Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada

Table 5 Drug-related risk behaviours and adverse health outcomes

Overall sample	N = 227
	n (%)
Bought drugs from a new dealer^a	106 (46.7)
Frequency of withdrawal/dopesickness has…^a
Increased	20 (11.9)
Decreased	6 (3.6)
Not changed	142 (84.5)
Overdosed by accident	19 (8.4)
Frequency of overdose has…
Increased	9 (4.0)
Decreased	9 (4.0)
Not changed	207 (91.2)
Don’t know	2 (0.88)
Has been feeling more depressed or anxious than usual	133 (58.6)

Subset reporting past six-month injection drug use	N = 94
	n (%)
Frequency of injecting drugs alone has…
Increased	12 (12.8)
Decreased	15 (16.0)
Not changed	67 (71.3)
Frequency of injecting drugs in public has…^b
Increased	14 (15.2)
Decreased	13 (14.1)
Not changed	65 (70.7)
Injected with people outside of usual partners^b	11 (11.8)
Injected with used needle-syringe or other injection materials^b	13 (14.3)

^aDenominators exclude participants reporting “don’t know” or “not applicable” (n = 68); many participants felt this question did not pertain to them, as they did not use opioids
^bDenominators exclude missing values (maximum n = 3)

ISSN: 1477-7517